Researcher
Tom Holvoet
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Internal medicine (Department)
Member
From1 Oct 2013 → 23 Sep 2018
Projects
1 - 1 of 1
- Local Rho kinase inhibition in murine colitis: mode of actionFrom1 Oct 2013 → 30 Sep 2017Funding: BOF - Other initiatives, FWO fellowships
Publications
1 - 10 of 23
- The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study(2022)
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro- Iglesias, Tom Holvoet, et al.
Pages: 1676 - 1686 - Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial(2022)
Authors: Marie Truyens, Triana Lobatón Ortega, Marc Ferrante, Peter Bossuyt, Séverine Vermeire, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, Guy Lambrecht, et al.
Pages: 1294 - 1305.e3 - Optimal management of acute severe ulcerative colitis (ASUC) : challenges and solutions(2021)
Authors: Tom Holvoet, Triana Lobatón Ortega
Pages: 71 - 81 - Vasomodulators and liver transplantation for portopulmonary hypertension : evidence from a systematic review and meta-analysis(2020)
Authors: Rebecca Deroo, Eric Trepo, Tom Holvoet, Michel De Pauw, Anja Geerts, Isabelle Colle, Michael B. Fallon, Sarah Raevens
Pages: 1701 - 1716 - Oral vasodilator treatment and liver transplantation for portopulmonary hypertension : systematic review and meta-analysis of hemodynamic response and prognosis(2019)Volume: 70
Authors: Rebecca Deroo, Michel De Pauw, Eric Trepo, Tom Holvoet, Anja Geerts, Isabelle Colle, Sarah Raevens
Pages: 272A - 272A - New insights into the treatment and pathophysiology of fibrostenotic CrohnU+2019s Disease(2018)
Authors: Tom Holvoet
- Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice(2017)
Authors: Lien Van den Bossche, Sarah Devriese, Sophie Van Welden, Tom Holvoet, Ramiro Vilchez Vargas, Marius Vital, Dietmar H Pieper, Julie Vandenbussche, Tom Van de Wiele, Debby Laukens
- Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor(2017)
Authors: Tom Holvoet, Sarah Devriese, Karolien Castermans, Sandro Boland, Dirk Leysen, Yves-Paul Vandewynckel, Lien Van den Bossche, Sophie Van Welden, Melissa Dullaers, Karel Geboes, et al.
Pages: 1054 - 1067 - Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis(2017)
Authors: Sophie Van Welden, Ben Wielockx, Melissa Dullaers, Sara Neyt, Benedicte Descamps, Sarah Devriese, Lien Van den Bossche, Tom Holvoet, Ann Baeyens, Carmen Correale, et al.
Pages: 547 - 558 - T84 monolayers are superior to Caco-2 as a model system of colonocytes(2017)
Authors: Sarah Devriese, Lien Van den Bossche, Sophie Van Welden, Tom Holvoet, Iris Pinheiro, Debby Laukens
Pages: 85 - 93